Shufro Rose & Co’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,630
Closed -$269K 342
2022
Q4
$269K Sell
9,630
-5,900
-38% -$151K 0.02% 254
2022
Q3
$363K Buy
15,530
+5,600
+56% +$169K 0.04% 197
2022
Q2
$335K Sell
9,930
-850
-8% -$29.8K 0.03% 215
2022
Q1
$377K Buy
+10,780
New +$369K 0.03% 212
2021
Q4
Sell
-6,490
Closed -$213K 318
2021
Q3
$213K Sell
6,490
-1,308
-17% -$41.9K 0.02% 261
2021
Q2
$236K Buy
+7,798
New +$257K 0.02% 248

Other funds holding OGN

Shufro Rose & Co's OGN Position: Q1 2023 in Review

Shufro Rose & Co sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 9,630 shares — an estimated $269K sold.

Shufro Rose & Co first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $377K in Q1 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Shufro Rose & Co reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Shufro Rose & Co sold 9,630 Organon & Co shares in Q1 2023, an estimated $269K.
  • Shufro Rose & Co first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • Shufro Rose & Co's Organon & Co position peaked at $377K in Q1 2022.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Shufro Rose & Co's 13F filing for Q1 2023, filed 20 Apr 2023.